000 01486 a2200409 4500
005 20250513080551.0
264 0 _c19930326
008 199303s 0 0 eng d
022 _a0006-2952
024 7 _a10.1016/0006-2952(93)90125-g
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLangley, S C
245 0 0 _aEffects of the glucocorticoid agonist, RU28362, and the antagonist RU486 on lung phosphatidylcholine and antioxidant enzyme development in the genetically obese Zucker rat.
_h[electronic resource]
260 _bBiochemical pharmacology
_cFeb 1993
300 _a543-51 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAndrostanols
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aBody Weight
_xdrug effects
650 0 4 _aEating
_xdrug effects
650 0 4 _aGlucocorticoids
_xantagonists & inhibitors
650 0 4 _aLung
_xdrug effects
650 0 4 _aMale
650 0 4 _aMifepristone
_xpharmacology
650 0 4 _aOrgan Size
_xdrug effects
650 0 4 _aPhospholipids
_xmetabolism
650 0 4 _aRats
650 0 4 _aRats, Zucker
650 0 4 _aReceptors, Glucocorticoid
_xantagonists & inhibitors
700 1 _aRickett, G W
700 1 _aHunt, A
700 1 _aKelly, F J
700 1 _aPostle, A D
700 1 _aYork, D A
773 0 _tBiochemical pharmacology
_gvol. 45
_gno. 3
_gp. 543-51
856 4 0 _uhttps://doi.org/10.1016/0006-2952(93)90125-g
_zAvailable from publisher's website
999 _c8442025
_d8442025